Antineoplastic and Immunosuppressive Agents Part I
Over the past two decades a number of attempts have been made, with varying degrees of success, to collect in a single treatise available information on the basic and applied pharmacology and biochemical mechanism of action of antineoplastic and immunosuppressive agents. The logarithmic growth of kn...
| Main Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1974, 1974
|
| Edition: | 1st ed. 1974 |
| Series: | Handbook of Experimental Pharmacology
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- I Table of Contents
- Section A: General Considerations: Antineoplastic Agents
- 1 Agents of Choice in Neoplastic Disease
- 2 Evaluation of Antineoplastic Activity: Requirements of Test Systems
- 3 Rational Design of Alkylating Agents
- 4 Rational Design of Folic Acid Antagonists
- 5 Rational Design of Purine Nucleoside Analogs
- 6 Rational Design of Pyrimidine Nucleoside Analogs
- 7 Basic Concepts of Cell Population Kinetics
- 8 Clinical Applications of Cell Cycle Kinetics
- 9 Metabolic Events in the Regulation of Cell Reproduction
- 10 Site of Action of Cytotoxic Agents in the Cell Life Cycle
- 11 Pharmacokinetic Models for Antineoplastic Agents
- 12 Absorption, Distribution, and Excretion of Antineoplastic and Immunosuppressive Agents
- 13 Transport of Antineoplastic Agents
- 14 Metabolism of Cancer Chemotherapeutic Agents via Pathways Utilized by Endogenous Substrates
- 15 Metabolism of Cancer Chemotherapeutic Agents via Pathways Utilized by Xenobiotics
- 16 Theoretical Considerations in the Chemotherapy of Brain Tumors
- 17 The Constancy of the Product of Concentration and Time
- 18 Biochemical Aspects of Selective Toxicity
- 19 Mechanisms of Resistance
- 20 Combination Chemotherapy: Basic Considerations
- 21 Combination Chemotherapy: Clinical Considerations
- 22 Tests Predictive of Cytotoxic Activity
- 23 Metabolic Changes Induced by Ionizing Radiations
- 24 Radiation Research: Survival Kinetics
- 25 Clinical and Laboratory Investigation of Combination Radiation and Chemical Therapy
- 26 Tumor Immunotherapy
- Section B: General Considerations: Immunosuppressive Agents
- 27 Evaluation of Immunosuppressive Agents
- 28 Immunosuppressive Agents
- 29 Clinical Utility of Immunosuppressive Agents
- Author Index